We are live on
!
Find out more
CS
Candriam SCA Portfolio holdings
AUM
$19.3B
1-Year Est. Return
39.18%
This Fund
S&P 500
This Quarter
Est. Return
+4.05%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$6.32B
AUM Growth
+$456M
(+7.8%)
Cap. Flow
+$224M
Cap. Flow
% of AUM
3.55%
Top 10 Holdings %
Top 10 Hldgs %
17.62%
Holding
844
New
72
Increased
349
Reduced
257
Closed
60
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$37.6M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$29.3M |
| 3 |
Biogen
BIIB
|
+$27.4M |
| 4 |
Home Depot
HD
|
+$22.7M |
| 5 |
Cisco
CSCO
|
+$21.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$23.6M |
| 2 |
TJX Companies
TJX
|
+$19.3M |
| 3 |
FedEx
FDX
|
+$16.4M |
| 4 |
Intuit
INTU
|
+$14.7M |
| 5 |
Corning
GLW
|
+$13.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.18% |
| 2 | Technology | 17.19% |
| 3 | Financials | 12.85% |
| 4 | Consumer Discretionary | 10.2% |
| 5 | Communication Services | 8.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CVG
676
DELISTED
Convergys
CVG
| $464K | 0.01% |
+19,000
| New | +$453K |
|
677
Ingredion
INGR
$6.38B
| $462K | 0.01% |
4,175
+2,000
| +92% | +$235K |
|
|
WRI
678
DELISTED
Weingarten Realty Investors
WRI
| $462K | 0.01% |
15,000
| – | – |
|
679
Compass Minerals
CMP
$1.24B
| $460K | 0.01% |
+7,000
| New | +$466K |
|
680
Haemonetics
HAE
$3.58B
| $448K | 0.01% |
+5,000
| New | +$422K |
|
|
FLG
681
Flagstar Bank National Association
FLG
$5.77B
| $448K | 0.01% |
13,537
+20
| +0.1% | +$719 |
|
682
BHP
BHP
$213B
| $446K | 0.01% |
+9,997
| New | +$433K |
|
683
Churchill Downs
CHDN
$6.03B
| $445K | 0.01% |
+9,000
| New | +$421K |
|
684
ICU Medical
ICUI
$3.93B
| $440K | 0.01% |
+1,500
| New | +$410K |
|
|
LPNT
685
DELISTED
LifePoint Health, Inc.
LPNT
| $439K | 0.01% |
+9,000
| New | +$466K |
|
686
Ralph Lauren
RL
$22.2B
| $433K | 0.01% |
+3,444
| New | +$418K |
|
|
AUY
687
DELISTED
Yamana Gold, Inc.
AUY
| $427K | 0.01% |
146,782
| – | – |
|
688
Jack in the Box
JACK
$278M
| $426K | 0.01% |
5,000
| – | – |
|
689
CGI
GIB
$13.9B
| $419K | 0.01% |
6,613
+338
| +5% | +$20.3K |
|
690
H&R Block
HRB
$5.18B
| $410K | 0.01% |
18,000
-17,471
| -49% | -$464K |
|
691
Verisk Analytics
VRSK
$26.4B
| $398K | 0.01% |
3,699
| – | – |
|
692
Vale
VALE
$62.9B
| $395K | 0.01% |
30,835
+10,500
| +52% | +$143K |
|
693
Cenovus Energy
CVE
$54.6B
| $391K | 0.01% |
37,642
+5,854
| +18% | +$59K |
|
|
NGD
694
DELISTED
New Gold Inc
NGD
| $391K | 0.01% |
187,898
| – | – |
|
695
CDW
CDW
$17.1B
| $389K | 0.01% |
+4,817
| New | +$373K |
|
|
TCON
696
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
| $386K | 0.01% |
715
| – | – |
|
697
Invesco NASDAQ Internet ETF
PNQI
$501M
| $384K | 0.01% |
+13,750
| New | +$369K |
|
|
AVDL
698
DELISTED
Avadel Pharmaceuticals
AVDL
| $380K | 0.01% |
62,000
| – | – |
|
699
Mercury Insurance
MCY
$5.94B
| $364K | 0.01% |
8,000
| – | – |
|
|
MNDT
700
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $346K | 0.01% |
22,500
| – | – |
|
Similar funds
PCM
A
MGP
LF
SOMRS
BPA
MIM
Candriam SCA's Q2 2018 Portfolio in Review
As of Q2 2018, Candriam SCA held 844 positions worth $6.32B, up 7.8% from $5.86B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Candriam SCA deployed $224M of net new capital in Q2 2018, opening 72 new positions and adding to 349 existing holdings. Its largest new stake was Broadcom: 1,532,450 shares worth $37.2M.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 23% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was JPMorgan Chase, an estimated $23.6M trimmed.
- Candriam SCA's largest Q2 2018 buy was Broadcom: 1,532,450 shares worth $37.2M.
- Candriam SCA added most to Bristol-Myers Squibb in Q2 2018, an estimated $29.3M increase.
- Candriam SCA's biggest Q2 2018 reduction was JPMorgan Chase, cutting an estimated $23.6M.
- Candriam SCA fully exited Monsanto Co in Q2 2018, selling an estimated $11.5M.
- Candriam SCA's ten largest holdings make up 18% of its $6.32B portfolio in Q2 2018.
- Candriam SCA opened 72 new positions and closed 60 in Q2 2018.
- Candriam SCA's portfolio value rose 7.8% quarter-over-quarter to $6.32B.
Based on Candriam SCA's 13F filing for Q2 2018, filed 14 Aug 2018.